SX-682: clinical trials recruiting now
3
Recruiting trials
5
Conditions studied
6
US states with sites
3
Countries
Phase breakdown
Phase 1 2
Phase 2 3
Conditions being studied
| Condition | Trials |
|---|---|
| Prostate cancer | 2 |
| Colorectal cancer | 1 |
| Metastatic Castrate-Resistant Prostate Cancer (mCRPC) | 1 |
| Metastatic Castration-resistant Prostate Cancer | 1 |
| Metastatic Colorectal Cancer | 1 |
Recruiting trials involving SX-682
- Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
- Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
- Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
Common questions
How many recruiting trials involve SX-682?
3 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.